Molecular Neurobiology

, Volume 55, Issue 6, pp 5232–5242 | Cite as

MicroRNA Profiling in Aging Brain of PSEN1/PSEN2 Double Knockout Mice

  • Suji Ham
  • Tae Kyoo Kim
  • Sangjoon Lee
  • Ya-Ping Tang
  • Heh-In Im


MicroRNAs are small non-coding RNAs that function as regulators of gene expression. The altered expression of microRNAs influences the pathogenesis of Alzheimer’s disease. Many researchers have focused on studies based on the relatively distinctive etiology of familial Alzheimer’s disease due to the absence of risk factors in the pathogenesis of sporadic Alzheimer’s disease. Although there is a limitation in Alzheimer’s disease studies, both Alzheimer’s disease types have a common risk factor—aging. No study to date has examined the aging factor in Alzheimer’s disease animal models with microRNAs. To investigate the effect of aging on the changes in microRNA expressions in the Alzheimer’s disease animal model, we selected 37 hippocampal microRNAs whose expression in 12- and 18-month aged mice changed significantly using microRNA microarray. On the basis of bioinformatics databases, 30 hippocampal microRNAs and their putative targets of PSEN1/PSEN2 double knockout mice were included in 28 pathways such as the wnt signaling pathway and ubiquitin-mediated proteolysis pathway. Cortical microRNAs and its putative targets involved in pathological aging were included in only four pathways such as the heparin sulfate biosynthesis. The altered expressions of these hippocampal microRNAs were associated to the imbalance between neurotoxic and neuroprotective functions and seemed to affect neurodegeneration in PSEN1/PSEN2 double knockout mice more severely than in wild-type mice. This microRNA profiling suggests that microRNAs play potential roles in the normal aging process, as well as in the Alzheimer’s disease process.


MicroRNA PSEN dKO mouse Alzheimer’s disease Aging Microarray Neurodegeneration 



Alzheimer’s diseases


Amyloid precursor protein


Database for annotation, visualization, and integrated discovery


Sporadic Alzheimer’s disease


Familial Alzheimer’s disease


Kyoto Encyclopedia of Genes and Genomes


Messenger RNA




Transforming growth factor


PSEN1/PSEN2 conditional double knockout


Wild type


X-linked inhibitor of apoptosis


BH3 interacting domain death agonist





This research was funded by the National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) (No. CRC-15-04-KIST).

Authors’ Contributions

H-II and Y-PT designed the study. H-II carried out the RNA isolation and microarray, and reviewed and commented on the manuscript. SH analyzed, interpreted data, and drafted the manuscript. SL interpreted data and helped in drafting the manuscript. Y-PT helped to design and review the study. TK discussed and edited the manuscript for submission. All authors read and approved the final manuscript.

Compliance with Ethical Standards

All procedures regarding the use and handling of mice were conducted as approved by the Institutional Animal Care and Use Committee (IACUC) of the Korea Institute of Science and Technology.

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Huntzinger E, Izaurralde E (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12(2):99–110CrossRefPubMedGoogle Scholar
  2. 2.
    Yan K, Jianban W, Liudi Y (2014) MicroRNA expression analysis of adult-onset drosophila Alzheimer’s disease model. Curr Alzheimer Res 11(9):882–891Google Scholar
  3. 3.
    Delay C, Hébert SS (2011) MicroRNAs and Alzheimer’s disease mouse models: current insights and future research avenues. International Journal of Alzheimer Disease 2011:6Google Scholar
  4. 4.
    Li N et al (2011) Up-regulation of key microRNAs, and inverse down-regulation of their predicted oxidative phosphorylation target genes, during aging in mouse brain. Neurobiol Aging 32(5):944–955CrossRefPubMedGoogle Scholar
  5. 5.
    Cheng L et al (2013) The detection of microRNA associated with Alzheimer’s disease in biological fluids using next-generation sequencing technologies. Front Genet 4:150CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gabrielle, S. What is early onset familial alzheimer disease (eFAD)? ; Available from:
  7. 7.
    Richard F, Amouyel P (2001) Genetic susceptibility factors for Alzheimer’s disease. Eur J Pharmacol 412(1):1–12CrossRefPubMedGoogle Scholar
  8. 8.
    Mirnics K et al (2008) Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice. Mol Neurodegener 3(1):14CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Chen Q et al (2008) Loss of presenilin function causes Alzheimer’s disease-like neurodegeneration in the mouse. J Neurosci Res 86(7):1615–1625CrossRefPubMedGoogle Scholar
  10. 10.
    Saura CA et al (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42(1):23–36CrossRefPubMedGoogle Scholar
  11. 11.
    Beglopoulos V et al (2004) Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem 279(45):46907–46914CrossRefPubMedGoogle Scholar
  12. 12.
    Wines-Samuelson M et al (2010) Characterization of age-dependent and progressive cortical neuronal degeneration in presenilin conditional mutant mice. PLoS One 5(4):e10195CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Elder GA, Gama Sosa MA, De Gasperi R (2010) Transgenic mouse models of Alzheimer’s disease. Mt Sinai J Med 77(1):69–81CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Corbett A, Williams G, Ballard C (2015) Drug repositioning in Alzheimer’s disease. Front Biosci (Schol Ed) 7:184–188CrossRefGoogle Scholar
  15. 15.
    Radde R et al (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7(9):940–946CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease. Trends Neurosci 31(9):454–463CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Lee JH et al (2015) Presenilin 1 maintains lysosomal ca(2+) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep 12(9):1430–1444CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Nixon RA, Cataldo AM (2006) Lysosomal system pathways: genes to neurodegeneration in Alzheimer’s disease. J Alzheimers Dis 9(3 Suppl):277–289CrossRefPubMedGoogle Scholar
  19. 19.
    Nixon RA, Yang DS (2011) Autophagy failure in Alzheimer’s disease—locating the primary defect. Neurobiol Dis 43(1):38–45CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Tu H et al (2006) Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer’s disease-linked mutations. Cell 126(5):981–993CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Cui X et al (2015) Network fingerprint: a knowledge-based characterization of biomedical networks. Sci Rep 5:13286CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Christie LA et al (2007) Differential regulation of inhibitors of apoptosis proteins in Alzheimer’s disease brains. Neurobiol Dis 26(1):165–173CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Hirota M et al (2008) Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cell Signal 20(9):1632–1641CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Song L et al (2014) Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling. Neural Regen Res 9(1):41–50CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Chou JJ et al (1999) Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96(5):615–624CrossRefPubMedGoogle Scholar
  26. 26.
    Treadway JL, Mendys P, Hoover DJ (2001) Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Expert Opin Investig Drugs 10(3):439–454CrossRefPubMedGoogle Scholar
  27. 27.
    Watanabe H et al (2014) Partial loss of presenilin impairs age-dependent neuronal survival in the cerebral cortex. J Neurosci 34(48):15912–15922CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Inestrosa NC, Varela-Nallar L (2014) Wnt signaling in the nervous system and in Alzheimer’s disease. J Mol Cell Biol 6(1):64–74CrossRefPubMedGoogle Scholar
  29. 29.
    Rosso SB, Inestrosa NC (2013) WNT signaling in neuronal maturation and synaptogenesis. Front Cell Neurosci 7:103CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Sun Q et al (2015) Cross-talk between TGF-beta/Smad pathway and Wnt/beta-catenin pathway in pathological scar formation. Int J Clin Exp Pathol 8(6):7631–7639PubMedPubMedCentralGoogle Scholar
  31. 31.
    Caraci F et al (2011) TGF-beta1 pathway as a new target for neuroprotection in Alzheimer’s disease. CNS Neurosci Ther 17(4):237–249CrossRefPubMedGoogle Scholar
  32. 32.
    von Bernhardi R et al (2015) Role of TGFbeta signaling in the pathogenesis of Alzheimer’s disease. Front Cell Neurosci 9:426Google Scholar
  33. 33.
    Vilchez D, Saez I, Dillin A (2014) The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun 5:5659CrossRefPubMedGoogle Scholar
  34. 34.
    Ciechanover A, Kwon YT (2015) Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 47:e147CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Galban S, Duckett CS (2010) XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ 17(1):54–60CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Vogt MC, Bruning JC (2013) CNS insulin signaling in the control of energy homeostasis and glucose metabolism—from embryo to old age. Trends Endocrinol Metab 24(2):76–84CrossRefPubMedGoogle Scholar
  37. 37.
    Tomlinson DR, Gardiner NJ (2008) Glucose neurotoxicity. Nat Rev Neurosci 9(1):36–45CrossRefPubMedGoogle Scholar
  38. 38.
    Jin K et al (2004) Enhanced neurogenesis in Alzheimer’s disease transgenic (PDGF-APPSw, Ind) mice. Proc Natl Acad Sci U S A 101(36):13363–13367CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Lopez-Toledano MA, Shelanski ML (2007) Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind). J Alzheimers Dis 12(3):229–240CrossRefPubMedGoogle Scholar
  40. 40.
    RF, Z, (2015) Of mice and men and Alzheimer disease: aging versus time. JSM Alzheimer’s Dis Relat Dement 2(2):1017Google Scholar
  41. 41.
    Age converter. Available from: Accessed 13 July 2016
  42. 42.
  43. 43.
    Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57CrossRefPubMedGoogle Scholar
  44. 44.
    Huang da W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1–13CrossRefPubMedGoogle Scholar
  45. 45.
    Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27–30CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Kanehisa M et al (2014) Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 42(Database issue):D199–D205CrossRefPubMedGoogle Scholar
  47. 47.
    Cline MS et al (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2(10):2366–2382CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Convergence Research Center for Diagnosis, Treatment and Care System of DementiaKorea Institute of Science and Technology (KIST)SeoulRepublic of Korea
  2. 2.Division of Bio-Medical Science &Technology, KIST SchoolKorea University of Science and TechnologySeoulRepublic of Korea
  3. 3.Department of BiologyBoston UniversityBostonUSA
  4. 4.Center for Neuroscience, Brain Science InstituteKorea Institute of Science and Technology (KIST)SeoulRepublic of Korea
  5. 5.Neuroscience Center of ExcellenceLouisiana State University Health New Orleans Sciences CenterNew OrleansUSA

Personalised recommendations